Role of Lung Ultrasound in Confirmation of Correct Double Lumen Endotracheal Tube Placement in Thoracic Surgeries

NCT ID: NCT04740385

Last Updated: 2022-07-19

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

117 participants

Study Classification

OBSERVATIONAL

Study Start Date

2021-02-03

Study Completion Date

2022-06-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

to assess the efficacy of lung ultrasound versus conventional auscultation method and fiberoptic bronchoscopy in confirmation of double lumen tube position

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Confirmation of double lumen tube position by auscultation followed fiberoptic bronchoscopy then lung ultrasound. After double lumen intubation all patient tube position will be confirmed using auscultation then fiberoptic bronchoscopy then lung ultrasound

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Diagnostic Accuracy

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

OTHER

Study Time Perspective

CROSS_SECTIONAL

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Lung cancer patients

Correct position of double lumen endotracheal tube will be assessed using lung sonography, routine chest auscultation and fiberoptic brochoscopy

Lung auscultation

Intervention Type DIAGNOSTIC_TEST

auscultation of air entry through chest wal

Fiberoptic bronchoscopy

Intervention Type DEVICE

Checking correct double lumen position through direct vision using fiberoptic bronchoscopy

Lung Ultrasound

Intervention Type DEVICE

real time visualization of air entry to the lungs using trans-thoracic lung ultrasound

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Lung auscultation

auscultation of air entry through chest wal

Intervention Type DIAGNOSTIC_TEST

Fiberoptic bronchoscopy

Checking correct double lumen position through direct vision using fiberoptic bronchoscopy

Intervention Type DEVICE

Lung Ultrasound

real time visualization of air entry to the lungs using trans-thoracic lung ultrasound

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* patients scheduled for surgeries under general anesthesia requiring double lumen endotracheal intubation
* ASA I-II

Exclusion Criteria

* patient refusal
Minimum Eligible Age

18 Years

Maximum Eligible Age

65 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

National Cancer Institute, Egypt

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Walaa Youssef Elsabeeny

Lecturer of anesthesia and pain management

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Walaa Y Elsabeeny, MD

Role: PRINCIPAL_INVESTIGATOR

Lecturer

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Department of anesthesia and pain medicine. National Cancer Institute

Cairo, , Egypt

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Egypt

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

202101-2P-02002

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Phrenic Identification in the ICU
NCT05875883 ACTIVE_NOT_RECRUITING